Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-04 4:30 pm Unchanged | 2026-05-15 | 13D | CITIUS ONCOLOGY INC CTOR | Citius Pharmaceuticals, Inc. CTXR | 66,049,615 71.000% | 0 (Unchanged) | Filing History |
| 2026-05-15 11:11 am Purchase | 2026-03-31 | 13G | CITIUS ONCOLOGY INC CTOR | Armistice Capital, LLC | 9,299,917 9.990% | 1,221,513 (+15.12%) | Filing History |
| 2026-02-17 9:52 pm Purchase | 2025-12-31 | 13G | CITIUS ONCOLOGY INC CTOR | Armistice Capital, LLC | 8,078,404 9.990% | 402,493 (+5.24%) | Filing History |
| 2025-12-17 4:10 pm Unchanged | 2025-12-10 | 13D | CITIUS ONCOLOGY INC CTOR | Citius Pharmaceuticals, Inc. CTXR | 66,049,615 77.900% | 0 (Unchanged) | Filing History |
| 2025-11-14 6:41 pm Purchase | 2025-09-30 | 13G | CITIUS ONCOLOGY INC CTOR | Armistice Capital, LLC | 7,675,911 9.790% | 7,675,911 (New Position) | Filing History |
| 2025-09-12 4:15 pm Unchanged | 2025-09-10 | 13D | CITIUS ONCOLOGY INC CTOR | Citius Pharmaceuticals, Inc. CTXR | 66,049,615 79.100% | 0 (Unchanged) | Filing History |
| 2025-07-25 5:00 pm Unchanged | 2025-07-17 | 13D | CITIUS ONCOLOGY INC CTOR | Citius Pharmaceuticals, Inc. CTXR | 66,049,615 84.300% | 0 (Unchanged) | Filing History |
| 2024-11-06 5:08 pm Sale | 2024-09-30 | 13G | CITIUS ONCOLOGY INC CTOR | Hudson Bay Capital Management LP | 0 0.000% | -500,000 (Position Closed) | Filing History |
| 2024-09-05 09:23 am Sale | 2024-08-02 | 13G | TENX KEANE ACQUISITION SHS TENK | Wolverine Asset Management, LLC | 0 0.000% | -567,211 (Position Closed) | Filing History |
| 2024-08-16 4:34 pm Purchase | 2024-08-12 | 13D | CITIUS ONCOLOGY INC CTOR | Citius Pharmaceuticals, Inc. CTXR | 66,049,615 92.600% | 66,049,615 (New Position) | Filing History |
| 2024-08-15 12:53 pm Sale | 2024-08-12 | 13D | CITIUS ONCOLOGY INC CTOR | 10XYZ Holdings LP | 1,978,954 2.800% | -65,046 (-3.18%) | Filing History |
| 2024-03-07 4:06 pm Sale | 2024-02-29 | 13G | TENX KEANE ACQUISITION SHS TENK | KARPUS MANAGEMENT, INC. | 0 0.000% | -504,610 (Position Closed) | Filing History |
| 2024-02-13 8:09 pm Purchase | 2023-12-31 | 13G | TENX KEANE ACQUISITION SHS TENK | MIZUHO FINANCIAL GROUP INC MFG | 522,030 5.840% | 522,030 (New Position) | Filing History |
| 2024-02-13 4:07 pm Purchase | 2023-12-31 | 13G | TENX KEANE ACQUISITION SHS TENK | KARPUS MANAGEMENT, INC. | 504,610 5.640% | 504,610 (New Position) | Filing History |
| 2024-02-08 4:07 pm Purchase | 2023-12-31 | 13G | TENX KEANE ACQUISITION SHS TENK | Wolverine Asset Management, LLC | 567,211 6.340% | 567,211 (New Position) | Filing History |
| 2024-02-05 3:37 pm Sale | 2023-12-31 | 13G | TENX KEANE ACQ UNITS 1 SHS & 1 TENKU | Space Summit Capital LLC | 0 0.000% | -441,678 (Position Closed) | Filing History |
| 2023-02-14 3:32 pm Sale | 2023-02-09 | 13G | TENX KEANE ACQUISITION SHS TENK | Feis Lawrence | 339,321 3.800% | -202,685 (-37.40%) | Filing History |
| 2023-02-10 4:39 pm Purchase | 2022-12-31 | 13G | TENX KEANE ACQUISITION SHS TENK | Hudson Bay Capital Management LP | 500,000 5.590% | 500,000 (New Position) | Filing History |
| 2023-02-08 08:39 am Purchase | 2022-12-31 | 13G | TENX KEANE ACQUISITION SHS TENK | Feis Lawrence | 542,006 6.060% | 33,187 (+6.52%) | Filing History |
| 2023-02-07 7:48 pm Sale | 2022-12-31 | 13G | TENX KEANE ACQ UNITS 1 SHS & 1 TENKU | Space Summit Capital LLC | 441,678 6.690% | -153,322 (-25.77%) | Filing History |